54350-48-0: Acitretin EP Impurity B

Acitretin EP Impurity B (CAS No: 54350-48-0) or Acitretin Related Compound B / Etretinate is a novel aromatic retinoic acid derivative used for the treatment of severe psoriasis and dyskeratoses. It acts by normalizing pathological variations in epidermal and dermal skin, especially by inhibiting hyperkeratinisation and cell differentiation.

Additional information

Catalogue No.

VE007789

CAS No.

54350-48-0

Molecular Formula

C23H30O3

Molecular Weight

354.5 g/mol

IUPAC Name

Ethyl (2E, 4E, 6E, 8E)-9-(4-methoxy-2, 3, 6-trimethylphenyl)-3, 7-dimethylnona-2, 4, 6, 8-tetraenoate

Synonyms

Acitretin Related Compound B/ Etretinate

References

?Ward, A., et al. “Etretinate a Review of Its Pharmacological Properties and Therapeutic Efficacy in Psoriasis and Other Skin Disorders.” Drugs, vol. 26, no. 1, July 1983, pp. 9–43, https://doi.org/10.2165/00003495-198326010-00002.

Status

In-stock